Radical Decarboxylation Toward Functionalization of Naphthoquinones
(CH3)3], 28.2 (CH2CAr) ppm. IR (ATR): ν = 3392, 2966, 2932,
FULL PAPER
added dropwise over 2 h. At the end of the addition, the reaction
˜
1704, 1656, 1591, 1514, 1304, 1269, 1250, 1158, 981, 966, 854, 777, mixture was stirred at 65 °C for 1 h. The mixture was cooled to
735, 702 cm–1. HRMS: calcd. for C17H19NNaO4 324.1212; found
324.1202; ∆ = 3.0 ppm.
room temperature, extracted with CH2Cl2, and washed with brine.
The organic layer was dried with MgSO4, filtered through Celite,
and concentrated under reduced pressure. Purification by flash
chromatography on silica gel with C6H12/AcOEt (10:0 to 9:1 and
finally 7:3) as the eluent led to the desired product as an orange
solid (240 mg, 0.58 mmol, 19% yield). 1H NMR (300 MHz,
CDCl3): δ = 8.07 [dd, J = 5.7 and 3.3 Hz, 2 H, CHCC(O)], 7.72
[dd, J = 5.7 and 3.3 Hz, 2 H, CHCHCC(O)], 5.61 (br. s, 2 H, NH),
4.45 (d, J = 6.3 Hz, 4 H, CH2NH), 1.40 [s, 18 H, OC(CH3)3] ppm.
13C NMR (75 MHz, CDCl3): δ = 185.5 [C(O)], 155.7 (NHCO),
142.8 (CArCH2), 133.9 [C(O)CAr], 131.8 [CHCC(O)], 126.4
[CHCHCC(O)], 79.7 [C(CH3)3], 36.3 (CH2NH), 28.3 [C(CH3)3]
tert-Butyl {2-[3-(2-tert-Butoxycarbonylaminoethyl)-1,4-dioxo-1,4-di-
hydronaphthalen-2-yl]ethyl}carbamate (17): This compound was ob-
tained along with 16 (method B described above) as an orange solid
(101 mg, 0.23 mmol, 12% yield). 1H NMR (300 MHz, CDCl3): δ
= 8.08 [dd, J = 5.7 and 3.3 Hz, 2 H, CHCC(O)], 7.70 [dd, J = 5.7
and 3.3 Hz, 2 H, CHCHCC(O)], 5.01 (br. s, 2 H, NH), 3.35 (t, J =
6.6 Hz, 4 H, CH2NH), 2.90 (t, J = 6.6 Hz, 4 H, CH2CAr), 1.35 [s,
18 H, OC(CH3)3] ppm. 13C NMR (75 MHz, CDCl3): δ = 184.9
[2ϫC(O)], 156.0 (2ϫNHCO), 145.5 (2ϫ=CCH2), 133.4
[2ϫCHCC(O)], 132.1 [2ϫCHCC(O)], 126.3 [2ϫCHCHCC(O)],
79.3 [2ϫC(CH3)3], 50.7 (2ϫCH2CH2NH), 39.9 (2ϫCH2NH),
ppm. IR (ATR): ν = 3354, 2975, 2927, 1690, 1661, 1594, 1507,
˜
1366, 1248, 1155, 938, 857, 762, 719 cm–1. HRMS: calcd. for
28.2 [2ϫC(CH ) ] ppm. IR (ATR): ν = 3365, 2925, 2852, 1689,
˜
3 3
C22H28N2NaO6 439.1845; found 439.1844; ∆ = 0.2 ppm.
1657, 1594, 1510, 1450, 1391, 1284, 1248, 1161, 971, 857, 780,
717 cm–1. HRMS: calcd. for C24H32N2NaO6 467.2158; found
467.2151; ∆ = 1.5 ppm.
2-Thioxo-2H-pyridin-1-yl 2-(tert-Butoxycarbonylamino)propionate
(23): Boc--alanine (446 mg, 2.36 mmol, 1 equiv.) and 2-mercap-
topyridine N-oxide (300 mg, 2.36 mmol, 1 equiv.) in CH2Cl2 (4 mL)
were added to a flask, which was protected from light by aluminum
foil at 0 °C in an ice bath. N-[3-(Dimethylamino)propyl]-NЈ-ethyl-
carbodiimide hydrochloride (452 mg, 2.36 mmol, 1 equiv.) was then
added, and the mixture was stirred at room temperature for 10 h.
After completion of the reaction, the organic phase was washed
twice with saturated aqueous NaHCO3 (10 mL) and then with
brine (10 mL). The aqueous phases, still protected from light, were
extracted CH2Cl2 (2ϫ10 mL), and the organic layers were dried
with MgSO4, filtered, and concentrated under reduced pressure.
The residue was quickly filtered through a small pad of silica gel
and washed with C6H12/AcOEt (1:1). The crude product was ob-
tained as a yellow oil (703 mg, 2.36 mmol, quantitative yield) and
used without further purification due to its instability. 1H NMR
(300 MHz, CDCl3): δ = 7.71 (m, 1 H, CHCHC=S), 7.25 (m, 2 H,
CHCHNO and CHC=S), 6.65 (m, 1 H, CHNO), 5.18 (br. s, 1 H,
NH), 4.63 (q, J = 6.7 Hz, 1 H, CHCH3), 1.73 (d, J = 6.7 Hz, 3 H,
CHCH3), 1.50 [s, 9 H, OC(CH3)3] ppm. 13C NMR (75 MHz,
CDCl3): δ = 174.9 (C=S), 169.4 (NOC=O), 155.2 (NHCOO), 137.7
(CHCHC=S), 137.0 (CHC=S), 133.4 (CHNO), 113.0 (CHCHNO),
80.4 [OC(CH3)3], 48.6 (CHCH3), 28.1 [C(CH3)3], 17.7 [CH(CH3)]
ppm.
tert-Butyl (1,4-Dioxo-1,4-dihydronaphthalen-2-ylmethyl)carbamate
(18): This compound was prepared according to the general pro-
cedure starting from NQ (950 mg, 6.00 mmol) and was purified by
flash chromatography on silica gel with CH2Cl2/CH3OH (10:0 to
95:5) as the eluent. The pure compound was obtained as an orange
solid (812 mg, 2.83 mmol, 47% yield). 1H NMR (300 MHz,
CDCl3): δ = 8.03 [dd, J = 5.1 and 3.3 Hz, 2 H, CHCC(O)], 7.71
[dd, J = 5.1 and 3.3 Hz, 2 H, CHCHCC(O)], 5.06 (br. s, 1 H, NH),
4.24 (d, J = 5.7 Hz, 2 H, CH2NH), 1.43 [s, 9 H, OC(CH3)3] ppm.
13C NMR (75 MHz, CDCl3): δ = 185.1 and 184.9 [C(O)CCH2 and
C(O)CCH3], 155.6 (NHCO), 147.2 (CH=CCH2), 133.98, 133.96
and 133.94 [=CCH2 and 2ϫCHCC(O)], 133.75 and 133.74
[2ϫCHCC(O)], 126.3 and 126.2 [2ϫCHCHCC(O)], 80.1
[C(CH ) ], 39.5 (CH NH), 28.3 [C(CH ) ] ppm. IR (ATR): ν =
˜
3 3
2
3 3
3378, 2971, 1686, 1658, 1634, 1520, 1363, 1336, 1251, 1162, 1050,
890, 859, 767, 683, 662 cm–1. HRMS: calcd. for C16H17NNaO4
310.1055; found 310.1069; ∆ = 4.4 ppm.
tert-Butyl {2-[3-(tert-Butoxycarbonylaminomethyl)-1,4-dioxo-1,4-di-
hydronaphthalen-2-yl]ethyl}carbamate (19): This compound was
prepared according to the general procedure starting from 18
(290 mg, 1.01 mmol) and was purified on silica gel with C6H12/
AcOEt (9:1 to 7:3) to yield the desired compound as an orange
solid (330 mg, 0.77 mmol, 76% yield). 1H NMR (300 MHz,
CDCl3): δ = 8.05 [m, 2 H, CHCC(O)], 7.70 [t, J = 3.3 Hz, 2 H,
CHCHCC(O)], 5.38 (br. s, 1 H, NH), 5.03 (br. s, 1 H, NH), 4.30
(d, J = 6.6 Hz, 2 H, =CCH2NH), 3.37 (m, 2 H, CH2CH2NH), 3.06
(m, 2 H, CH2CH2NH), 1.41 [s, 9 H, OC(CH3)3], 1.23 [s, 9 H,
OC(CH3)3] ppm. 13C NMR (75 MHz, CDCl3): δ = 185.7 and 185.0
[2ϫC(O)], 156.1 and 156.0 (2ϫNHCO), 145.8 [=C(CH2)], 142.7
[=C(CH2)2], 133.8 and 133.7 [2ϫC(O)CAr], 132.2 and 131.8
[2ϫCHCC(O)], 126.6 and 126.0 [2ϫCHCHCC(O)], 79.8 and 79.1
[2ϫC(CH3)3], 43.4 (CH2CH2NH), 31.5 and 30.1 (2ϫCH2NH),
2-Thioxo-2H-pyridin-1-yl 3-(tert-Butoxycarbonylamino)propionate
(24): This compound was prepared according to the procedure de-
scribed for 23 starting from 2-mercaptopyridine N-oxide (150 mg,
1.18 mmol) and was obtained as a yellow oil (350 mg, 1.18 mmol,
quantitative yield). 1H NMR (300 MHz, CDCl3): δ = 7.71 (m, 1
H, CHCHC=S), 7.25 (m, 2 H, CHCHNO and CHC=S), 6.67 (m,
1 H, CHNO), 5.52 (br. s, 1 H, NH), 3.64 (m, 2 H, CH2NH), 2.91
(m, 2 H, CH2CO), 1.47 [s, 9 H, OC(CH3)3] ppm. 13C NMR
(75 MHz, CDCl3): δ = 175.4 (C=S), 167.4 (NOC=O), 155.8
(NHCOO), 137.7 (CHCHC=S), 136.9 (CHC=S), 133.8 (CHNO),
112.7 (CHCHNO), 79.4 [OC(CH3)3], 36.0 (CH2N), 33.1
(CHCH2N), 28.2 [C(CH3)3] ppm.
28.3 and 28.1 [2ϫC(CH ) ] ppm. IR (ATR): ν = 3381, 2977, 2930,
˜
3 3
1702, 1664, 1595, 1512, 1367, 1294, 1251, 1164, 859 cm–1. HRMS:
Supporting Information (see footnote on the first page of this arti-
cle): NMR spectra of all synthesized compounds are available.
calcd. for C23H30N2NaO6 453.2002; found 453.2019; ∆ = 3.8 ppm.
tert-Butyl [3-(tert-Butoxycarbonylaminomethyl)-1,4-dioxo-1,4-dihy-
dronaphthalen-2-ylmethyl]carbamate (20): To a solution of NQ
(475 mg, 3.00 mmol, 0.1 ) in CH3CN/H2O (2:1, 30 mL) was added
Boc-glycine (1.58 g, 9 mmol, 3 equiv.) and Boc-β-alanine (1.7 g,
9 mmol, 3 equiv.), and the mixture was warmed to 65 °C. Silver
nitrate (153 mg, 0.9 mmol, 0.6 equiv.) was added to the stirred mix-
ture. A homogeneous solution of ammonium persulfate (890 mg,
Acknowledgments
CNRS, Université de Bordeaux I, Ligue Nationale Contre le Can-
cer (Comité de la Dordogne), Association pour la Recherche sur le
Cancer, (postdoctoral grant to Cl. C.) and Fluofarma are gratefully
3.9 mmol, 2.6 equiv., 0.3 ) in CH3CN/H2O (2:1, 15 mL) was acknowledged for financial support. The authors warmly thank
Eur. J. Org. Chem. 2007, 3045–3052
© 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
3051